The tumor-immune microenvironment (TME) in HR+/HER2-metastatic breast cancer (mBC): Relationship to non-metastatic (met) tumors and prior treatment (tx) received.-MedSci.cn

The tumor-immune microenvironment (TME) in HR+/HER2-metastatic breast cancer (mBC): Relationship to non-metastatic (met) tumors and prior treatment (tx) received.

Waks, AG; Tolaney, SM; Schnitt, SJ; Dillon, D; Gjini, E; Abdelrahman, S

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (15):

科室
- - 订阅+
  - 更多科室
工具
服务